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Abstract: Adipose tissue senescence is implicated as a major player in obesity- and ageing-related
disorders. There is a growing body of research studying relevant mechanisms in age-related diseases,
as well as the use of adipose-derived stem cells in regenerative medicine. The cell banking of tissue
by utilising cryopreservation would allow for much greater flexibility of use. Dimethyl sulfoxide
(DMSO) is the most commonly used cryopreservative agent but is toxic to cells. Trehalose is a sugar
synthesised by lower organisms to withstand extreme cold and drought that has been trialled as a
cryopreservative agent. To examine the efficacy of trehalose in the cryopreservation of human adipose
tissue, we conducted a systematic review of studies that used trehalose for the cryopreservation of
human adipose tissues and adipose-derived stem cells. Thirteen articles, including fourteen studies,
were included in the final review. All seven studies that examined DMSO and trehalose showed that
they could be combined effectively to cryopreserve adipocytes. Although studies that compared
nonpermeable trehalose with DMSO found trehalose to be inferior, studies that devised methods
to deliver nonpermeable trehalose into the cell found it comparable to DMSO. Trehalose is only
comparable to DMSO when methods are devised to introduce it into the cell. There is some evidence
to support using trehalose instead of using no cryopreservative agent.
Keywords: adipose-derived stem cells; cryopreservation; trehalose; lipoaspirate; autologous fat
grafting; ageing
1. Introduction
Ageing results in adipose tissue dysfunction, resulting in systemic effects such as
peripheral insulin resistance and inflammation. Cellular senescence and progenitor cell
dysfunction are also seen in ageing adipose tissues, and these may represent potential
therapeutic targets in age-related disease. Adipose tissue comprises many cell types,
generally divided into two fractions: the adipocyte fraction (AF), which contains primarily
mature adipocytes, and the stromovascular fraction (SVF), which comprises progenitor
cells (including adipose-derived stem cells, ADCSs), pericytes, and fibroblasts. Keeping
these cells in long-term culture for clinical use or research has inherent limitations, and cell
banking of tissue by utilising cryopreservation would allow for much greater flexibility of
use [1].
ADSCs also show great promise in regenerative medicine as these cells can differenti-
ate into several different cell types, which can be used for tissue regeneration. For example,
ADSCs can differentiate into a large number of cell types, which include chondrogenic,
myogenic, osteogenic, angiogenic, and neuronal lineages [2]. With regard to the identifi-
cation of ADSCs, the Mesenchymal and Tissue Stem Cell Committee of the International
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Society for Cellular Therapy have proposed minimal criteria to define human mesenchymal
stem cells. First, they must be plastic-adherent. Second, they must express the cell surface
markers CD105, CD73 and CD90, and lack the expression of CD45, CD34, CD14 or CD11b,
CD79alpha or CD19 and HLA-DR. Third, they must differentiate to osteoblasts, adipocytes
and chondroblasts in vitro [3].
Various methods of stromal vascular fraction cryopreservation have been demon-
strated [4], but the protocol which maximises cell viability remains unclear. Biospecimens
have to reach cryogenic temperatures (−196 ◦C) before long-term storage in liquid ni-
trogen. They are then warmed back to normothermic temperature (37 ◦C) as necessary.
Two methods have been described for cryopreservation: slow-freezing and vitrification.
Slow-freezing cools specimens at a low rate of about 1 ◦C/min to reduce intracellular ice
formation. The disadvantage of this technique is that it can cause excessive dehydration,
leading to osmotic stress, and deformation. Vitrification involves rapid cooling without
ice formation but requires a high concentration of cryoprotective agent (CPA), and there
may be limitations on the sample volume [5]. Both methods require adding a CPA to
adipose tissue prior to cooling, which is a critical step in the optimal cryopreservation of
human ADSCs.
Dimethyl sulfoxide (DMSO) is the most commonly used CPA in the cryopreservation
of ADSCs. DMSO is a small amphipathic molecule with two non-polar methyl groups
and a polar sulfoxide group. The solvent activity of DMSO allows it to readily cross cell
membranes. DMSO helps prevent the formation of intracellular ice, thereby protecting
the tissue from freezing injuries and helping achieve maximum tissue survival during the
freezing and thawing process. DMSO is toxic to cells at room temperature and washing and
centrifugation are needed after thawing to remove it from the tissue [6]. This is particularly
important in clinical settings when stem cells are administered in vivo as a cell therapy,
where inadvertent administration of DMSO can cause severe side effects or death [7].
Furthermore, high centrifugation speeds during the washing and removal of CPAs may
damage the fragile adipose tissue after freezing/thawing [8]. The ideal cryopreservation
agent should be non-toxic for cells and patients, non-antigenic and chemically inert. It
should ideally not require washing prior to transplantation [9].
Owing to their low toxicity, sugars have been used as extracellular cryopreservation
agents. Trehalose (α-d-glucopyranosyl α-d-glucopyranoside) is a disaccharide of glucose
with low toxicity in contrast to DMSO. It is synthesised by species of bacteria, fungi, yeast,
insects and plants that are prone to dehydration but is absent from vertebrates [10]. Such
organisms can withstand dehydration and extreme cold. The suggested mechanisms for
the protein-stabilising effect of trehalose include water replacement, glass transition and
chemical stability [11]. Trehalose acts to replace water molecules and form hydrogen
bonds with proteins, maintaining protein conformation in conditions of dehydration [12].
In the dehydrated state, trehalose forms a non-crystalline glass that reduces molecular
movement, inhibiting metabolic activity and protein breakdown. Trehalose also acts to
stabilise the phospholipid bilayer when in its “clam-shaped” conformation [13]. As the
plasma membrane of mammalian cells is impermeable to trehalose, intracellular delivery
is vital for cryopreservation [14,15]. The precise mechanism by which trehalose provides
such protection is yet to be fully elucidated and recent studies have demonstrated adequate
outcomes with only trehalose in the cryopreservation of various tissues [16–20]. Autologous
fat could potentially be banked and used later without having to remove any agent from
the cryopreserved fat grafts while providing useful long-term cryopreservation [21–23].
This result may be through a possible synergistic mechanism.
In an update on the cryopreservation of adipose tissue and ADSCs, Shu et al. [24]
highlighted that slow-freezing (1–2 ◦C/min) with a combination of CPAs and rapid thawing
produced optimal results and that ADSCs can retain high degrees of cell viability. This is the
first review that specifically examines the role of trehalose as a CPA in the cryopreservation
of human adipose tissue and ADSCs.
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2. Materials and Methods
A systematic review was performed using the following databases: PubMed, CINAHL,
Web of Science, MEDLINE, Cochrane Library and EMBASE. We included the following
keywords and search terms: adipose stem cells, cryopreservation, trehalose, lipoaspirate,
autologous fat grafting and cryopreservation. Those keywords were searched in that order
in each database. We used a snowballing technique with an arbitrary cut-off of greater than
two hundred articles for each database. An initial reviewer performed the search before
being checked by a second reviewer. Any disputes about inclusion were resolved by a
third reviewer.
The following inclusion criteria were applied: (1) interventional studies using trehalose
in the cryopreservation of human adipose-derived stem cells, including case series, case–
control, cohort studies and randomised controlled trials; (2) studies translated into the
English language; and (3) full article accessible.
Exclusion criteria: (1) unpublished literature; (2) literature published before 2000;
(3) articles not available for free viewing; and (4) studies using animal adipose-derived
stem cells.
A total of 430 articles were retrieved. A total of thirteen articles with fourteen suitable
studies were relevant for this systematic literature review. The studies included and
excluded are summarised in Figure 1. Formal statistical analysis was not performed
because of the methodologic heterogeneity demonstrated among the articles.
Figure 1. Flow diagram showing the literature search.
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3. Results
3.1. Combined Use of Trehalose and DMSO for Cryopreservation
Eight studies were included and are described in Table 1. All studies report improved
viability of adipocytes following a freeze/thaw cycle if a CPA (trehalose and DMSO com-
bined) was used compared to controls where no CPA was used. A variety of concentrations
of trehalose and DMSO were used, and no significant conclusions can be drawn about
the optimum concentration/combinations for optimum adipocyte yield. The cells were
washed to remove the CPA according to standard protocols.
Pu et al. [25] tested their hypothesis that adipose aspirates obtained from conventional
lipoplasty could be cryopreserved. They cryopreserved adipose tissues using slow cooling
and fast rewarming rates. The combination of trehalose and DMSO resulted in significantly
more viable adipocytes with better function than simple cryopreservation with liquid
nitrogen. They concluded that the combination appears to provide adequate preservation
of adipose tissues obtained from conventional lipoplasty.
In a later study, Pu et al. [25] injected adipose aspirates into the posterior scalp of
athymic nude mice. They assessed the gross appearance of the fat grafts for volume, weight
and histology. The trehalose and DMSO combinations maintained better weight, volume
and tissue architecture than the simple cryopreservation group. The results of both cryop-
reserved groups were less satisfactory than the fresh fat control group. They concluded
that the DMSO and trehalose combination provided reasonably good cryopreservation
of adipose tissues. De Rosa et al. [26] tested different concentrations of CPA. When tre-
halose and DMSO were combined, cells recovered more than 80% of their viability post
cryopreservation, with antigen expression levels close to those seen in freshly isolated cells.
Cui et al. [27] compared trehalose alone to a combination of DMSO and trehalose.
They injected cryopreserved fat grafts into the posterior scalp of a nude mouse. They found
that trehalose was comparable to DMSO and trehalose in providing adequate protection
during cryopreservation.
Pu et al. [22] found in an in vitro study that cryopreservation with trehalose and DMSO
combined yielded on average 90% of adipocytes compared to the fresh fat control. Cui
et al. [23] investigated different concentrations of CPAs in vitro and found that 0.5 mol/L
DMSO and 0.2 mol/L trehalose were the most effective and were significantly better
than simple cryopreservation without CPAs. They went on to perform an in vivo study
using 0.5 mol/L DMSO and 0.2 mol/L trehalose to cryopreserve adipose aspirates. The
adipose aspirates were injected into a nude mouse and compared to controls. The DMSO
and trehalose group had significantly more retained weight and volume of the injected
fat grafts than the simple cryopreservation group. Pu et al. [28] tested a combination of
0.5 mol/L DMSO and 0.2 mol/L trehalose. They found that the combination of CPAs
maintained a similar number of viable adipocytes and histology of the cells to the fresh fat
control. However, they did report that glycerol-3-phosphatase dehydrogenase activity was
significantly lower than the control, indicating a decrease in adipocyte cellular function in
this group.
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Table 1. Cryopreservation with trehalose and dimethyl sulfoxide combined.
Ref. Level ofEvidence OCEBM
Methods, Slow Cooling and
Rapid Rewarming CPA Concentration mol/L, Groups
Temperature,
◦C Time Results
Pu et al. [21]
2004 Level 3
Adipose aspirates from lipoplasty were
randomised to each group and were
evaluated by viable adipocyte counts,
G3PDH assay and routine histology.
(1) Simple cryopreservation with
liquid nitrogen only; (2) 0.5 mol/L
DMSO + 0.2 mol/L trehalose; and
(3) Control group with fresh adipose
−196 20 min
Group 2 showed significantly higher
adipocyte viability and superior cellular
function of adipocytes compared to
group 1. (2.15 ± 0.68 vs.
1.04 ± 0.35 × 106/mL, P < 0.0001)
Pu et al. [25]
2006 Level 3
Cryopreserved adipocytes from
cosmetic lipoplasty were administered
into the posterior scalp of a nude
mouse. Gross appearance of fat grafts
was observed for up to 16 weeks. At the
end of the study, final graft weight and
volume and corresponding histology
were determined.
(1) 0.5 mol/L DMSO + 0.2 mol/L
trehalose solution; (2) Simple
cryopreservation with liquid nitrogen
only; and (3) Control group with fresh
adipose aspirates
−196 20 min
Group 1 showed greater graft weight,
volume and retained tissue architecture
when compared to group 2 (P < 0.0001);
the fresh control group showed a
greater retained volume
(47.7% ± 18.6%), and this was
statistically significant relative to both
groups 1 (35.3% ± 7.8%, P < 0.05) and
2 (6.5% ± 3.7%, P < 0.0001).
De Rosa et al.
[26] 2009 Level 3
Different concentrations of CPA were
evaluated to preserve ADSCs for future
clinical applications.
(1) 1% DMSO (0.1 mol/L), 9%
trehalose (0.26 mol/L), 90% FBS;
(2) 4% DMSO (0.6 mol/L), 6%
trehalose (0.18 mol/L), 90% FBS;
(3) 8% DMSO (1.1 mol/L), 2%
trehalose (0.06 mol/L), 90% FBS; and
(4) 10% DMSO (1.4 mol/L), 90% FBS
−196 1, 6 and12 months
The best freezing solution consisted of
90% FBS, 4% DMSO (0.6 mol/L) and
6% trehalose. The thawed cells in this
group showed superior differentiation
efficiency and higher levels of antigen
expression, similar levels found in
fresh isolates.
Cui et al. [27]
2010 Level 3
0.5 mL of cryopreserved adipocyte
grafts was thawed and injected into the
posterior scalps of mice for 8 weeks.
Graft volume, weight and histology
were evaluated at the end of the study.
(1) 0.5 mol/L DMSO + 0.2 mol/L
trehalose; (2) 0.35 mol/L trehalose;
and (3) Control (fresh fat graft)
−196 20 min
Groups 1 and 2 showed no statistically
significant difference in maintained
volume (vs. 46.1% ± 14.4% vs.
38.2% ± 10.1%, NS) and weight
(38.9% ± 14.7% vs. 34.1% ± 12.1%, NS).
Both cryopreservation groups were
found to be inferior to control
(both P < 0.05).
Pu et al. [22]
2006 Level 3
In vitro study measuring the rate of
growth and viable cell count (after 2
weeks) of fresh vs. cryopreserved (with
fast rewarming) adipocyte aspirates.
(1) 0.5 mol/L DMSO + 0.2 mol/L
trehalose and (2) Control fresh
adipose aspirates
−196 20 min
The cryopreserved aspirates produced
90% of the cell count from fresh
aspirates (3.7 ± 1.4 × 105 processed
lipoaspirate cells per millilitre aspirates
vs. 4.1 ± 1.4 × 105 cells/mL).
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Table 1. Cont.
Ref. Level ofEvidence OCEBM
Methods, Slow Cooling and
Rapid Rewarming CPA Concentration mol/L, Groups
Temperature,
◦C Time Results
Cui et al. [23]
2007 Level 3
Different CPAs and their concentrations
were tested in vitro.
(1) Fresh adipose aspirates;
(2) Cryopreserved adipose aspirates
without cryoprotectants; and
(3) Cryopreserved adipose aspirates
with cryoprotectants—0.2 mol/L
DMSO + 0.1 mol/L trehalose,
0.5 mol/L DMSO + 0.2 mol/L
trehalose, 0.25 mol/L trehalose,
0.5 mol/L trehalose, 1.0 mol/L
DMSO, 1.5 mol/L DMSO
−196 20 min
The combination of 0.5 mol/L DMSO
and 0.2 mol/L trehalose produced the
greatest adipocyte count; group 3
produced a significantly higher
adipocyte count than group 2
(2.06 ± 0.54 × 106/mL vs.
1.07 ± 0.41 × 106/mL, P < 0.0011);
group 1 displayed only a marginally
higher adipocyte count relative to
group 3 (vs. 2.57 ± 0.56 × 106/mL vs.
2.06 ± 0.54 × 106/mL, P = 0.083);
group 3 displayed less tissue shrinkage
relative to group 2.
Cui et al. [23]
2007 Level 3
1 mL fat graft was injected into nude
mice and subsequently harvested 4
months later and analysed for volume,
weight and histology. Maintenance of
tissue architecture was rated as per the
following scale: “5-pristine cellular
architecture in all sections examined;
4-mild disruption of cellular
architecture in <50% of sections; 3-mild
disruption of cellular architecture in
>50% of sections; 2-severe disruption of
cellular architecture in <50% of sections;
1-severe disruption of cellular
architecture in >50% of sections”.
(1) Fresh adipose aspirates;
(2) Cryopreserved adipose aspirates
without CPAs; and (3) Cryopreserved
adipose aspirates with
CPAs—0.5 mol/L DMSO + 0.2 mol/L
trehalose
−196 1 week
Retained graft volume and weight were
significantly higher in group 3
compared to group 2 (both P < 0.0001);
histology showed extensive tissue
fibrosis in group 2, in contrast to
relatively preserved tissue architecture
with very little fibrosis in group 3; the
mean histological rating score in group
1 was significantly higher than that of
group 2 (4.60 ± 0.22 vs. 1.50 ± 0.26,
P < 0.0001).
Pu et al. [28]
2010 Level 3
The fat graft samples from both groups
were evaluated with trypan blue vital
staining, G3PDH assay and routine
histology.
(1) 0.5 mol/L DMSO and 0.2 mol/L
trehalose and (2) Fresh fat graft
control
−196 20 min
Groups 1 and 2 showed similar
adipocyte counts (3.46 ± 0.91 vs.
4.12 ± 1.11 × 106/mL, P = 0.22);
activity of G3PDH was significantly
higher in group 2 compared with group
1 (0.66 ± 0.09 vs. 0.47 ± 0.09 U/mL,
P < 0.001); histological analysis showed
mainly normal structure of fragmented
fatty tissues in both groups.
OCEBM: Oxford Centre for Evidence-Based Medicine; CPA: Cryoprotective agent; G3PDH: Glycerol-3-phosphate dehydrogenase; DMSO: Dimethyl sulfoxide; FBS: Foetal bovine serum; NS: Not significant;
ADSC: Adipose-derived stem cell.
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3.2. Comparing Trehalose vs. DMSO for Cryopreservation
Four Level 3 studies were available for analysis (Table 2). Two studies showed
noninferior outcomes when trehalose was used as a CPA [7,15] when compared with
DMSO, while two studies showed inferior outcomes [29,30]. Inferior outcomes were seen
when no additional techniques were used to encourage the intracellular trafficking of
trehalose (e.g., electroporation) [29,30].
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Rao et al. [15] examined trehalose as a sole cryoprotectant. They achieved effective
delivery into human ADSCs (hADSCs) and reported that preincubation with trehalose
significantly increased post-cryopreservation cell viability to 88.1% ± 7.5%. The viabil-
ity is further improved to 91.2% ± 3.4% by using a higher concentration of trehalose.
This observed cell viability was similar to the DMSO group (88.2% ± 2.2%), indicat-
ing that trehalose was successfully delivered into the hADSCs during cryopreservation.
Dovgan et al. [7] demonstrated that electroporation is an efficient method for delivering
trehalose into hADSCs. They achieved a high survival rate approaching the values ob-
tained with standard DMSO protocol (91.5% ± 1.6%). The authors observed no statistically
significant difference between 250 mmol/L trehalose and DMSO, and with only a slight
difference between 400 mmol/L trehalose and DMSO.
Roato et al. [29] compared DMSO and trehalose, and both agents showed similar
degrees of viability of samples after thawing. However, the hADSCs cryopreserved in
DMSO had a more rapid growth and arrived at confluence in a few days with a better
morphology than those treated with trehalose. They concluded that DMSO is superior to
trehalose for the cryopreservation of adipose tissue. Yong et al. [30] compared the effects of
different combinations of trehalose, DMSO and FBS on hADSCs in terms of cell phenotype,
proliferation potential, differentiation potential, stemness and viability. They found that
ADSCs preserved in 250 mmol/L trehalose showed the lowest degree of cell viability
(P < 0.05).
3.3. Comparing Trehalose with Fresh Fat Control or Simple Cryopreservation
Four studies were included for analysis (Table 3). Study protocols were heterogenous
and included studies that used nanoparticles to mediate the intracellular delivery of
trehalose [15], while others did not. The data appear to suggest that the use of a CPA (such
as trehalose) has better outcomes than not using a CPA in terms of cell viability and cell
differentiation after freezing and thawing.
Cui et al. [27] examined the use of trehalose as a single CPA of adipose aspirates and
found that a concentration of 0.35 mol/L appeared to provide optimal cryopreservation.
They also found that when a glycerol-3-phosphate dehydrogenase assay was performed to
assess cellular function, there was no difference between any of the trehalose groups and
the fresh fat control. In the second part of the study, cryopreserved fat was injected into the
posterior scalp of a nude mouse. They found that at 4 months the volume and weight of the
grafts were significantly lower than those of the fresh fat controls (P < 0.5). Rao et al. [15]
used nanoparticle-mediated intracellular delivery of trehalose into adipocytes and found
that the morphology and differentiation of cells were comparable between the fresh fat
control group and the trehalose group. Pu et al. [31] and Cui et al. [23] reported that the
trehalose group had a significant reduction in viable adipocytes compared to the fresh fat
control. Both authors also said that the trehalose groups had significantly higher viable
adipocyte counts than the simple cryopreservation group that used no CPA. It is important
to note that cryopreservation is not typically carried out without a CPA so there is limited
utility in this comparison.
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Methods, Slow Cooling and
Rapid Rewarming CPA Concentration mol/L, Groups
Temperature,
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Cui et al. [6]
2009 Level 3
Adipose aspirates were
cryopreserved using trehalose as a
CPA in seven different
concentrations and compared to a
fresh fat control group for viability
in vitro. A G3PDH assay was also
performed to assess intracellular
function.
Trehalose: (1) 0.20 mol/L;
(2) 0.25 mol/L; (3) 0.30 mol/L;
(4) 0.35 mol/L; (5) 0.40 mol/L;
(6) 0.50 mol/L; (7) 0.75 mol/L; and
(8) Control
−196 20 min
Cryopreservation with 0.35 mol/L
trehalose was found to preserve the most
adipocytes. This concentration of trehalose
showed no statistical difference relative to
control (2.4 ± 0.52 vs.
1.88 ± 0.61 × 106/mL; P > 0.05). No
concentration of trehalose showed a
significant difference in intracellular
function relative to control (all P > 0.05).
Cui et al. [27]
2010 Level 3
0.5 mL of cryopreserved fat grafts
was thawed and injected into the
posterior scalps of mice for 8 weeks.
Weight, volume and histology of
grafts were analysed at the end of
the study.
(1) 0.5 mol/L DMSO + 0.2 mol/L
trehalose; (2) 0.35 mol/L trehalose;
and (3) Control (fresh fat graft)
−196 20 min
Group 2 and group 1 were inferior to the
control group (both P < 0.05). There was a
significantly higher percentage of
maintained volume of injected fat in the
control group (55.5% ± 11.7%) compared to
group 1 (46.1% ± 14.4%, P < 0.05) or
group 2 (38.2% ± 10.5%, P < 0.01). The
control group showed a significantly higher
maintained weight relative to both groups 1
(38.9% ± 14.7%, P < 0.01) and 2
(34.1% ± 12.1%, P < 0.01).
Rao et al. [15]
2015 Level 3
To determine the cryopreservation
of primary hADSCs using
nanoparticle-mediated intracellular
delivery of trehalose as the sole
CPA.
(1) 0.2 mol/L trehalose;
(2) 100 mL/L DMSO; and
(3) Fresh control
−196 1 day
hADSCs’ tissue architecture post
cryopreservation with trehalose is similar
to that of fresh isolates. Trehalose
maintained comparable differentiation
capabilities of the cryopreserved vs. fresh
hADSCs. Trehalose acted as a successful
cryoprotectant.






Methods, Slow Cooling and
Rapid Rewarming CPA Concentration mol/L, Groups
Temperature,
◦C Time Results
Pu et al. [31]
2005 Level 3
The efficacy of trehalose as the sole
CPA for cryopreservation of
adipocytes, with the aim to develop
a protocol which enables optimal
preservation of adipose tissues.
(1) Control fresh adipose aspirates;
(2) Simple cryopreservation group:
cryopreserved adipose aspirates
without CPAs; and (3) Optimal
cryopreservation group: 0.25 mol/L
trehalose
−196 20 min
Adipocyte count was significantly higher in
group 3 than group 2 (1.78 ± 0.33 vs.
0.99 ± 0.35 × 106/mL, P < 0.0001).
Adipocyte count in group 3 was
significantly lower than fresh isolates
(1.78 ± 0.33 vs. 2.64 ± 0.54 × 106/mL,
P < 0.001). The G3PDH activity in group 3
was also significantly lower than control
(0.24 ± 0.07 vs. 0.32 ± 0.09 U/mL, P < 0.05).
There was a statistically significant increase
in G3PDH activity, which was significantly
higher in group 3 relative to group 2
(0.24 ± 0.07 vs. 0.15 ± 0.06 U/mL,
P < 0.01).
Cui et al. [23]
2007 Level 3
In vitro study where different
cryoprotectant agents and their
concentrations were tested.
(1) Fresh adipose aspirates; (2)
Cryopreserved adipose aspirates
without CPAs; and (3)
Cryopreserved adipose aspirates
with CPAs. (1) 0.2 mol/L DMSO +
0.1 mol/L trehalose; (2) 0.5 mol/L
DMSO + 0.2 mol/L trehalose; (3)
0.25 mol/L trehalose; (4) 0.5 mol/L
trehalose; (5) 1.0 mol/L DMSO; and
(6) 1.5 mol/L DMSO
−196 20 min
The viable adipocyte count in the fresh fat
control group was still significantly higher
than the count in any of the six different
CPA groups (all P < 0.0001). Significantly
higher integrated viable adipocyte count of
adipose aspirates was found in group 3
compared with group 2
(2.06 ± 0.54 × 106/mL vs. 1.07 ± 0.41 ×
106/mL, P < 0.001).
OCEBM: Oxford Centre for Evidence-Based Medicine; CPA: Cryoprotective agent; hADSCs: Human adipose-derived stem cells; DMSO: Dimethyl sulfoxide; G3PDH: Glycerol-3-phosphate dehydrogenase.
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4. Discussion
There are several limitations to this review. Firstly, there is an English language bias in
our search strategy as only articles published in English were reviewed. However, a study
by Juni et al. [32] found that this has little effect on the estimation of summary treatment
effect. Secondly, several variables influence the viability of cryopreserved adipose tissue,
including harvest technique, storage temperature and duration, thawing rate and the
associated surgical procedure [24]. The individual contribution of each factor is not clearly
understood, therefore making it difficult to draw comparisons between the studies. Thirdly,
tissues were frozen for short times in several studies, which is not typical of tissue and cell
banking applications.
The results from eight studies in our systematic review showed that DMSO and
trehalose could be combined effectively to cryopreserve adipocytes. The advantage of this
combination is that it reduces the dose of DMSO required. All four studies comparing
trehalose and DMSO to simple cryotherapy with liquid nitrogen alone found a significant
improvement in cryopreservation [21,23,25]. Pu et al. [6,22,25,28] found in four studies
that the combination of trehalose and DMSO acted as successful CPAs with the number of
adipocytes comparing very well to the fresh fat controls. In contrast, Cui et al. [23,27] found
that this combination of CPAs was inferior to the fresh fat control groups. Interestingly De
Rosa et al. [26] found that the combination of trehalose and DMSO performed better than
DMSO alone. This result is in line with the hypothesis that these two CPAs may have a
synergistic effect.
To maximise cell viability, a balance is required between reducing intracellular ice
formation (by cooling slowly) and cooling quickly enough to minimise the solution effects.
Mazur proposed a two-factor hypothesis attributing a lower cell survival rate when the
cooling rate is slower than optimal (due to alterations in the solute concentrations of the
extracellular and intracellular solutions). A faster cooling rate than optimal also decreases
cell survival due to intracellular ice formation [33–36]. The storage temperature is an
important variable. Erdim et al. [37] found that the storage of adipose tissue at 4 ◦C
reduced the number of live fat cells compared to freshly isolated cells, but this was not
statistically significant (P > 0.05). Wolter et al. [38] compared storing cryopreserved fat cells
at −20 ◦C and −80 ◦C for up to 30 days. They found that −80 ◦C yielded higher viability
than −20 ◦C, with the latter leading to nonviable tissue.
Storage temperature is thought to significantly influence the viability of cryopreserved
adipose tissue. Subzero temperatures result in ice formation damage, but this can be
mitigated by the storage of tissue at less than −70 ◦C. Rapid thawing can improve cell
viability by reducing the risk of intracellular ice formation, and subsequent ice crystal
growth. Son et al. [39] performed a study that showed that adipocytes’ viability rapidly
declined following frozen storage for one day at both −15 ◦C and −70 ◦C and subsequently
decreased slowly in storage after eight weeks. By this point, only around 5% of the
fat cells remained viable, suggesting that both these storage conditions are not ideal for
cryopreservation. Hwang et al. [40] compared the survival rates of adipose tissue in various
thawing conditions, such as natural thawing at 25 ◦C for 15 min; natural thawing at 25 ◦C
for 5 min, followed by rapid thawing at 37 ◦C in a water bath for 5 min; and rapid thawing
at 37 ◦C for 10 min in a water bath. The authors found a rapid thaw at 37 ◦C for 10 min
in a water bath to be the optimal method for thawing the cryopreserved adipose tissue.
The freezing behaviour of the cells can be modified by the addition of CPAs, which affect
the rates of water transport, ice nucleation and ice crystal growth. MacRae et al. [41]
cryopreserved adipose tissue with and without CPAs. They concluded that at −196 ◦C,
adipose tissue preserved with CPAs showed increased viability compared to that preserved
without CPAs, thus demonstrating their importance.
Long-term cryopreserved ADSCs demonstrate a low risk of tumorigenicity and there-
fore offer great potential in regenerative medicine [30]. Developing successful serum-free
and xeno-free defined cryopreservation methods will enable more widespread clinical ap-
plications of stem cells [42]. The literature suggests a combination of extracellular trehalose
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with a penetrating CPA appears to be efficient [42], and the potential benefits of using
trehalose as a CPA are well-described. However, delivering sufficient quantities intracellu-
larly remains a hurdle. Various techniques have been described, including microinjection
into the cell, electroporation, fluid phase endocytosis, engineered transmembrane pores
and nanoparticles. The optimum method for this is still under investigation. Outcomes
in the literature are heterogenous because cryopreservation protocols may result in insuf-
ficient trafficking of trehalose into cells, or the delivery step (e.g., electroporation) might
compromise cellular integrity and affect their ability to withstand further stresses induced
by the freezing [43]. Further studies are therefore required to develop an effective approach
for the intracellular delivery of trehalose for cell cryopreservation.
Finally, there remains some variation in the cryopreservation of tissues and further
studies are required to determine optimal protocols. Choudhery et al. demonstrated that
adipose tissue could be successfully cryopreserved without compromising cell morphology,
as well as subsequent proliferation and differentiation potential [1], making this a useful
tool in regenerative medicine. However, more work needs to be performed on charac-
terising the optimal cryopreservation techniques for the different tissues and cell types
of interest.
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